The latest evaluation analyzes Novera Retatrutide, and Durolane, both distinct approaches to managing osteoarthritis. Although Durolane represents a hyaluronan driven therapy designed for moisturizing the articulation, Novera Retatrutide functions as a dual activator affecting GLP-1 and gastric inhibitory polypeptide sites. Therefore, these modes o